Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia
Abstract The COVID-19 crisis has had profound impacts on health service provision, particularly those providing client facing services. Supervised injecting facilities and drug consumption rooms across the world have been particularly challenged during the pandemic, as have their client group—people...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | Harm Reduction Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12954-021-00471-x |
id |
doaj-7d264e39b9a34bf597c7af4598112b0e |
---|---|
record_format |
Article |
spelling |
doaj-7d264e39b9a34bf597c7af4598112b0e2021-02-21T12:05:26ZengBMCHarm Reduction Journal1477-75172021-02-0118111010.1186/s12954-021-00471-xAdapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in AustraliaAmanda Roxburgh0Marianne Jauncey1Carolyn Day2Mark Bartlett3Shelley Cogger4Paul Dietze5Suzanne Nielsen6Julie Latimer7Nico Clark8Health Risks Program, Burnet InstituteDiscipline of Addiction Medicine, the Central Clinical School, Sydney Medical School, the Faculty of Medicine and Health, University of SydneyDiscipline of Addiction Medicine, the Central Clinical School, Sydney Medical School, the Faculty of Medicine and Health, University of SydneyUniting Medically Supervised Injecting CentreNorth Richmond Community Health Medically Supervised Injecting RoomHealth Risks Program, Burnet InstituteHealth Risks Program, Burnet InstituteUniting Medically Supervised Injecting CentreNorth Richmond Community Health Medically Supervised Injecting RoomAbstract The COVID-19 crisis has had profound impacts on health service provision, particularly those providing client facing services. Supervised injecting facilities and drug consumption rooms across the world have been particularly challenged during the pandemic, as have their client group—people who consume drugs. Several services across Europe and North America closed due to difficulties complying with physical distancing requirements. In contrast, the two supervised injecting facilities in Australia (the Uniting Medically Supervised Injecting Centre—MSIC—in Sydney and the North Richmond Community Health Medically Supervised Injecting Room—MSIR—in Melbourne) remained open (as at the time of writing—December 2020). Both services have implemented a comprehensive range of strategies to continue providing safer injecting spaces as well as communicating crucial health information and facilitating access to ancillary services (such as accommodation) and drug treatment for their clients. This paper documents these strategies and the challenges both services are facing during the pandemic. Remaining open poses potential risks relating to COVID-19 transmission for both staff and clients. However, given the harms associated with closing these services, which include the potential loss of life from injecting in unsafe/unsupervised environments, the public and individual health benefits of remaining open are greater. Both services are deemed ‘essential health services’, and their continued operation has important benefits for people who inject drugs in Sydney and Melbourne.https://doi.org/10.1186/s12954-021-00471-xHarm reductionSupervised injecting facilitiesDrug consumption roomsCOVID-19People who inject drugs |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Amanda Roxburgh Marianne Jauncey Carolyn Day Mark Bartlett Shelley Cogger Paul Dietze Suzanne Nielsen Julie Latimer Nico Clark |
spellingShingle |
Amanda Roxburgh Marianne Jauncey Carolyn Day Mark Bartlett Shelley Cogger Paul Dietze Suzanne Nielsen Julie Latimer Nico Clark Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia Harm Reduction Journal Harm reduction Supervised injecting facilities Drug consumption rooms COVID-19 People who inject drugs |
author_facet |
Amanda Roxburgh Marianne Jauncey Carolyn Day Mark Bartlett Shelley Cogger Paul Dietze Suzanne Nielsen Julie Latimer Nico Clark |
author_sort |
Amanda Roxburgh |
title |
Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia |
title_short |
Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia |
title_full |
Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia |
title_fullStr |
Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia |
title_full_unstemmed |
Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia |
title_sort |
adapting harm reduction services during covid-19: lessons from the supervised injecting facilities in australia |
publisher |
BMC |
series |
Harm Reduction Journal |
issn |
1477-7517 |
publishDate |
2021-02-01 |
description |
Abstract The COVID-19 crisis has had profound impacts on health service provision, particularly those providing client facing services. Supervised injecting facilities and drug consumption rooms across the world have been particularly challenged during the pandemic, as have their client group—people who consume drugs. Several services across Europe and North America closed due to difficulties complying with physical distancing requirements. In contrast, the two supervised injecting facilities in Australia (the Uniting Medically Supervised Injecting Centre—MSIC—in Sydney and the North Richmond Community Health Medically Supervised Injecting Room—MSIR—in Melbourne) remained open (as at the time of writing—December 2020). Both services have implemented a comprehensive range of strategies to continue providing safer injecting spaces as well as communicating crucial health information and facilitating access to ancillary services (such as accommodation) and drug treatment for their clients. This paper documents these strategies and the challenges both services are facing during the pandemic. Remaining open poses potential risks relating to COVID-19 transmission for both staff and clients. However, given the harms associated with closing these services, which include the potential loss of life from injecting in unsafe/unsupervised environments, the public and individual health benefits of remaining open are greater. Both services are deemed ‘essential health services’, and their continued operation has important benefits for people who inject drugs in Sydney and Melbourne. |
topic |
Harm reduction Supervised injecting facilities Drug consumption rooms COVID-19 People who inject drugs |
url |
https://doi.org/10.1186/s12954-021-00471-x |
work_keys_str_mv |
AT amandaroxburgh adaptingharmreductionservicesduringcovid19lessonsfromthesupervisedinjectingfacilitiesinaustralia AT mariannejauncey adaptingharmreductionservicesduringcovid19lessonsfromthesupervisedinjectingfacilitiesinaustralia AT carolynday adaptingharmreductionservicesduringcovid19lessonsfromthesupervisedinjectingfacilitiesinaustralia AT markbartlett adaptingharmreductionservicesduringcovid19lessonsfromthesupervisedinjectingfacilitiesinaustralia AT shelleycogger adaptingharmreductionservicesduringcovid19lessonsfromthesupervisedinjectingfacilitiesinaustralia AT pauldietze adaptingharmreductionservicesduringcovid19lessonsfromthesupervisedinjectingfacilitiesinaustralia AT suzannenielsen adaptingharmreductionservicesduringcovid19lessonsfromthesupervisedinjectingfacilitiesinaustralia AT julielatimer adaptingharmreductionservicesduringcovid19lessonsfromthesupervisedinjectingfacilitiesinaustralia AT nicoclark adaptingharmreductionservicesduringcovid19lessonsfromthesupervisedinjectingfacilitiesinaustralia |
_version_ |
1724258516004241408 |